Alan Huang

Alan Huang is currently an Advisor at Casdin Capital since 2021.
Prior to this, he was the Chief Scientific Officer at Tango Therapeutics, Inc. from 2018 to 2023.
He worked at Novartis AG as a Senior Director from 2009 to 2015 and at Novartis Institutes of Biomedical Research as a Senior Director & Global Head-Oncology from 2003 to 2016.
He also worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. Additionally, he holds a doctorate degree from the University of South Alabama, which he received in 1998, and an undergraduate degree from Fudan University, which he received in 1993.